Welcome to Agalimmune
Agalimmune is a biopharmaceutical company with an innovative anti-cancer technology for the treatment of patients with solid tumors.
Our vision is to harness the power of the cancer patient’s own immune system to specifically target the tumor; not only to kill the tumor cells but also to bring about a long-lasting protective anti-tumor immune response.
In addition to its ongoing efforts to develop cancer treatments, Agalimmune also establishes partnerships and collaborations with leading institutions and companies to research and develop pioneering targeted cancer vaccines and cell-based immunotherapeutic products. These internal and external efforts will continue to position Agalimmune at the cutting edge of innovative anti-cancer technologies.